<> Jagsonpal Pharmaceuticals Share Price Today: Live Jagsonpal Pharmaceuticals Share Price NSE/BSE | 5paisa
JAGSNPHARM

Jagsonpal Pharmaceuticals Share PriceJagsonpal Pharmaceuticals

₹332.85
-2.3 (-0.69%)
As on 05 February, 2023 | 17:23 BSE: 507789 NSE: JAGSNPHARM

Jagsonpal Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Jagsonpal Pharmaceuticals

Start SIP

Jagsonpal Pharmaceuticals Share Price

  • Over 1 Month -9.91%
  • Over 3 Month -1.04%
  • Over 6 Month -6.92%
  • Over 1 Year 98.48%

Jagsonpal Pharmaceuticals Key Statistics

P/E Ratio 53.8
PEG Ratio -1.6
Market Cap Cr 872
Price to Book Ratio 7.1
EPS 7.5
Dividend 0
Relative Strength Index 30.37
Money Flow Index 20.36
MACD Signal -2.54
Average True Range 15.36

Jagsonpal Pharmaceuticals Investment Rating

  • Master Rating:
  • Jagsonpal Pharmaceuticals has an operating revenue of Rs. 227.73 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 12% is healthy, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 19% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Jagsonpal Pharmaceuticals Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 616152
Operating Expenses Qtr Cr 485452
Operating Profit Qtr Cr 1361
Depreciation Qtr Cr 001
Interest Qtr Cr 000
Tax Qtr Cr 300
Net Profit Qtr Cr 1000

Jagsonpal Pharmaceuticals Technicals

EMA & SMA

Current Price
₹332.85
-2.3 (-0.69%)
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • 355.21
  • 50 Day
  • 357.58
  • 100 Day
  • 353.14
  • 200 Day
  • 329.7
  • 20 Day
  • 359.88
  • 50 Day
  • 359.23
  • 100 Day
  • 356.07
  • 200 Day
  • 342.56

Jagsonpal Pharmaceuticals Resistance and Support

PIVOT
₹339.27
Resistance
First Resistance 346.54
Second Resistance 357.92
Third Resistance 365.19
RSI 30.37
MFI 20.36
MACD Single Line -2.54
MACD -6.44
Support
First Resistance 327.89
Second Resistance 320.62
Third Resistance 309.24

Jagsonpal Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 24,528 1,380,681 56.29
Week 13,948 815,272 58.45
1 Month 20,724 956,406 46.15
6 Month 48,359 2,265,623 46.85

Jagsonpal Pharmaceuticals Result Highlights

Jagsonpal Pharmaceuticals Synopsis

NSE-Medical-Diversified

Jagsonpal Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 226.10 Cr. and Equity Capital is Rs. 13.10 Cr. for the Year ended 31/03/2022. Jagsonpal Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 17/08/1978 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1978PLC009181 and registration number is 009181.
Market Cap 867
Sales 228
Shares in Float 0.81
No of funds 6
Yield 1.07
Book Value 7.04
U/D Vol ratio 1.8
LTDebt / Equity
Alpha 0.33
Beta 0.86

Jagsonpal Pharmaceuticals

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 68.71%68.71%68.71%
Mutual Funds
Foreign Portfolio Investors 0.11%0.13%
Financial Institutions/ Banks
Individual Investors 21.12%22.77%25.26%
Others 10.06%8.39%6.03%

Jagsonpal Pharmaceuticals Management

Name Designation
Mr. R P S Kochhar Chairman Emeritus
Mr. Manish Gupta Managing Director
Mr. Harsha Raghavan Non Executive Director
Mr. Prithipal Singh Kochhar Non Executive Director
Mr. Debasis Bikash Nandy Ind. Non-Executive Director
Ms. Radhika Madhukar Dudhat Ind. Non-Executive Director
Ms. Pallavi Dinodia Gupta Ind. Non-Executive Director

Jagsonpal Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Jagsonpal Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-02-08 Quarterly Results
2022-11-09 Quarterly Results
2022-08-09 Quarterly Results
2022-05-30 Audited & Quarterly Results
2022-05-13 Others
Date Purpose Remarks
2021-11-01 INTERIM Rs.4.00 per share(80%)Interim Dividend

Jagsonpal Pharmaceuticals MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Jagsonpal Pharmaceuticals FAQs

What is Share Price of Jagsonpal Pharmaceuticals ?

Jagsonpal Pharmaceuticals share price is ₹332 As on 05 February, 2023 | 17:09

What is the Market Cap of Jagsonpal Pharmaceuticals ?

The Market Cap of Jagsonpal Pharmaceuticals is ₹872 Cr As on 05 February, 2023 | 17:09

What is the P/E ratio of Jagsonpal Pharmaceuticals ?

The P/E ratio of Jagsonpal Pharmaceuticals is 53.8 As on 05 February, 2023 | 17:09

What is the PB ratio of Jagsonpal Pharmaceuticals ?

The PB ratio of Jagsonpal Pharmaceuticals is 7.1 As on 05 February, 2023 | 17:09

Q2FY23